Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 449-459 , December 2009

Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: Glucose versus insulin

  • Ilse Vanhorebeek, PhD (Associate Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +32 16 330242; Fax +32 16 330932.
    • ,
  • Lies Langouche, PhD (Post-doctoral Fellow)

      Affiliations

    • Tel.: +32 16 330242; Fax: +32 16 330932.

References 

  1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Critical Care Clinics. 2001;17:107–124
  2. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest. 2007;132:268–278
  3. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  4. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. European Heart Journal. 2006;27:2716–2724
  5. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–1353
  6. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine. 2006;354:449–461
  7. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373:547–556
  8. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–3159
  9. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. American Journal of Respiratory and Critical Care Medicine. 2007;175:480–489
  10. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine Practice. 2004;10(Suppl. 2):46–52
  11. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings. 2004;79:992–1000
  12. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Seminars in Thoracic and Cardiovascular Surgery. 2006;18:302–308
  13. Reed CC, Stewart RM, Sherman M, et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. Journal of American College of Surgeons. 2007;204:1048–1054
  14. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Journal of Neurosurgical Anesthesiology. 2007;19:156–160
  15. Lecomte P, Van Vlem B, Coddens J, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Critical Care (London, England). 2008;12:R154
  16. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine. 2009;360:1283–1297
  17. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine. 2008;358:125–139
  18. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. The Journal of Clinical Endocrinology and Metabolism. 2009;94:3163–3170
  19. Van den Berghe G, Mesotten D, Vanhorebeek I. Intensive insulin therapy in the intensive care unit. Canadian Medical Association Journal. 2009;180:799–800
  20. Inzucchi SE, Siegel MD. Glucose control in the ICU–how tight is too tight?. The New England Journal of Medicine. 2009;360:1346–1349
  21. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal. 2009;180:821–827
  22. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN Journal of Parenteral and Enteral Nutrition. 2006;30:164–172
  23. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Critical Care Medicine. 2003;31:359–366
  24. Van den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. Journal of Clinical Endocrinology and Metabolism. 1999;84:1311–1323
  25. Van den Berghe G, Baxter RC, Weekers F, et al. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. Journal of Clinical Endocrinology and Metabolism. 2000;85:183–192
  26. Mesotten D, Delhanty PJ, Vanderhoydonc F, et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. Journal of Clinical Endocrinology and Metabolism. 2002;87:5516–5523
  27. Watt MJ, Howlett KF, Febbraio MA, et al. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. The Journal of Physiology. 2001;534:269–278
  28. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism. 1979;28:1031–1039
  29. Wolfe RR, Herndon DN, Jahoor F, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. The New England Journal of Medicine. 1987;317:403–408
  30. Virkamaki A, Yki-Jarvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology. 1994;134:2072–2078
  31. Stephens JM, Bagby GJ, Pekala PH, et al. Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochemical and Biophysical Research. 1992;183:417–422
  32. Virkamaki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. The Journal of Clinical Investigation. 1999;103:931–943
  33. Langouche L, Vander Perre S, Wouters PJ, et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. Journal of Clinical Endocrinology and Metabolism. 2007;92:3890–3897
  34. Mesotten D, Swinnen JV, Vanderhoydonc F, et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. Journal of Clinical Endocrinology and Metabolism. 2004;89:219–226
  35. Mesotten D, Wouters PJ, Peeters RP, et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. Journal of Clinical Endocrinology and Metabolism. 2004;89:3105–3113
  36. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings. 2003;78:1471–1478
  37. Langouche L, Meersseman W, Vander Perre S, et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Critical Care Medicine. 2008;36:1475–1480
  38. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096–1105
  39. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–3777
  40. Singer M, Brealey D. Mitochondrial dysfunction in sepsis. Biochemical Society Symposis. 1999;66:149–166
  41. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219–223
  42. Brealey D, Karyampudi S, Jacques TS, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2004;286:R491–R497
  43. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation. 2005;115:2277–2286
  44. Vanhorebeek I, De Vos R, Mesotten D, et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005;365:53–59
  45. Siroen MP, van Leeuwen PA, Nijveldt RJ, et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Critical Care Medicine. 2005;33:504–510
  46. Ellger B, Langouche L, Richir M, et al. Modulation of regional nitric oxide metabolism: blood glucose control or insulin?. Intensive Care Medicine. 2008;34:1525–1533
  47. Ellger B, Richir MC, van Leeuwen PA, et al. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology. 2008;149:3148–3157
  48. Vanhorebeek I, Ellger B, De Vos R, et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Critical Care Medicine. 2009;37:1355–1364
  49. Vanhorebeek I, Gunst J, Ellger B, et al. Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney International. 2009;76:512–520
  50. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820
  51. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Annals of Surgery. 1996;224:97–102
  52. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Critical Care Medicine. 2005;33:2235–2240
  53. Thornalley PJ. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochemical Journal. 1988;254:751–755
  54. Berlanga J, Cibrian D, Guillen I, et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clinical Science (London). 2005;109:83–95
  55. Rosca MG, Monnier VM, Szweda LI, Weiss MF. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. American Journal of Physiology. Renal Physiology. 2002;283:F52–F59
  56. Shangari N, Bruce WR, Poon R, O'Brien PJ. Toxicity of glyoxals–role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochemical Society Transactions. 2003;31:1390–1393
  57. Rosca MG, Mustata TG, Kinter MT, et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. American Journal of Physiology. Renal Physiology. 2005;289:F420–F430
  58. Grune T, Berger MM. Markers of oxidative stress in ICU clinical settings: present and future. Current Opinion in Clinical Nutrition and Metabolic Care. 2007;10:712–717
  59. Eaton S. The biochemical basis of antioxidant therapy in critical illness. Proceedings of the Nutrition Society. 2006;65:242–249
  60. Pacher P, Szabo C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxidants & Redox Signaling. 2005;7:1568–1580
  61. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochemical Journal. 1988;256:205–212
  62. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Current Opinion in Clinical Nutrition and Metabolic Care. 2002;5:561–568
  63. Suh SW, Gum ET, Hamby AM, et al. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. The Journal of Clinical Investigation. 2007;117:910–918
  64. West IC. Radicals and oxidative stress in diabetes. Diabetic Medicine. 2000;17:171–180
  65. Aulak KS, Koeck T, Crabb JW, Stuehr DJ. Dynamics of protein nitration in cells and mitochondria. American Journal of Physiology. Heart and Circulatory Physiology. 2004;286:H30–H38
  66. Frost MT, Wang Q, Moncada S, Singer M. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005;288:R394–R400
  67. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Critical Care Medicine. 2005;33:1624–1633
  68. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes. 1989;38:1031–1035
  69. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Medicine. 2003;29:642–645
  70. Rassias AJ, Marrin CA, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia & Analgesia. 1999;88:1011–1016
  71. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. The Journal of Trauma. 1990;30:830–832
  72. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Annals of Thoracic Surgery. 1999;67:352–360
  73. Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabetic Medicine. 1994;11:935–941
  74. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. Journal of Clinical Endocrinology and Metabolism. 2003;88:1082–1088
  75. Weekers F, Van Herck E, Coopmans W, et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology. 2002;143:764–774
  76. Weekers F, Michalaki M, Coopmans W, et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology. 2004;145:205–213
  77. Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. Journal of American Medical Association. 2000;283:221–228
  78. Nordt TK, Sawa H, Fujii S, Sobel BE. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation. 1995;91:764–770
  79. Stegenga ME, van der Crabben SN, Levi M, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55:1807–1812
  80. Vaidyula VR, Rao AK, Mozzoli M, et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes. 2006;55:202–208
  81. Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism. 2000;49:147–150
  82. Dandona P, Aljada A, Mohanty P, et al. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care. 2003;26:3310–3314
  83. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. Journal of Clinical Endocrinology and Metabolism. 2001;86:3257–3265
  84. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology. 2004;25:4–7
  85. Aljada A, Ghanim H, Mohanty P, et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. Journal of Clinical Endocrinology and Metabolism. 2002;87:1419–1422
  86. Savioli M, Cugno M, Polli F, et al. Tight glycemic control may favor fibrinolysis in patients with sepsis. Critical Care Medicine. 2009;37:424–431
  87. Agus MS, Javid PJ, Ryan DP, Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. Journal of Pediatric Surgery. 2004;39:839–844
  88. Gore DC, Wolf SE, Sanford AP, et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. American Journal of Physiology. Endocrinology and Metabolism. 2004;286:E529–E534
  89. Vanhorebeek I, Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Current Opinion in Pharmacology. 2004;4:621–628
  90. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144:5329–5338
  91. Solomon V, Madihally S, Yarmush M, Toner M. Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. The Journal of Surgical Research. 2000;93:120–126
  92. Flakoll PJ, Hill JO, Abumrad NN. Acute hyperglycemia enhances proteolysis in normal man. American Journal of Physiology. 1993;265:E715–E721
  93. Gore DC, Chinkes DL, Hart DW, et al. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Critical Care Medicine. 2002;30:2438–2442
  94. Sodi-Pallares D, Testelli MR, Fishleder BL, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. American Journal of Cardiology. 1962;9:166–181
  95. Das UN. Insulin: an endogenous cardioprotector. Current Opinion in Critical Care. 2003;9:375–383
  96. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology. 1995;26:57–65
  97. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal. 2005;26:650–661
  98. The CREATE-ECLA Trial Group Investigators . Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Journal of American Medical Association. 2005;293:437–446
  99. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105:1497–1502
  100. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurology. 2007;6:397–406
  101. Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Current Opinion in Clinical Nutrition and Metabolic Care. 2002;5:153–158
  102. Lanza-Jacoby S, Wong SH, Tabares A, et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochimica et Biophysica Acta. 1992;1124:233–240
  103. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Annals of Surgery. 2004;239:553–560
  104. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. The Journal of Clinical Investigation. 1990;86:696–702
  105. Garcia-Marin JJ, Villanueva GR, Esteller A. Diabetes-induced cholestasis in the rat: possible role of hyperglycemia and hypoinsulinemia. Hepatology. 1988;8:332–340
  106. Gielkens HA, Lam WF, Coenraad M, et al. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. Journal of Hepatology. 1998;28:595–602
  107. Nakeeb A, Comuzzie AG, Al-Azzawi H, et al. Insulin resistance causes human gallbladder dysmotility. Journal of Gastrointestinal Surgery. 2006;10:940–948
  108. Mesotten D, Wauters J, Van den Berghe G, et al. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. Journal of Clinical Endocrinology and Metabolism. 2009;
  109. Fernandez-Real JM, Pugeat M, Emptoz-Bonneton A, Ricart W. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance. Metabolism. 2001;50:1248–1252
  110. Vanhorebeek I, Peeters RP, Vander Perre S, et al. Cortisol response to critical illness: effect of intensive insulin therapy. Journal of Clinical Endocrinology and Metabolism. 2006;91:3803–3813
  111. Peeters RP, Hagendorf A, Vanhorebeek I, et al. Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Clinical Endocrinology (Oxford). 2009;71:145–153

PII: S1521-6896(09)00052-4

doi: 10.1016/j.bpa.2009.08.008

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 449-459 , December 2009

Article Tools